These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28712731)

  • 1. Cervical dystonia patients display subclinical gait changes.
    Esposito M; Dubbioso R; Peluso S; Picone A; Corrado B; Servodio Iammarone C; Allocca R; Manganelli F; Santoro L; Fasano A
    Parkinsonism Relat Disord; 2017 Oct; 43():97-100. PubMed ID: 28712731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A and cervical dystonia: a seven-year follow-up.
    Camargo CH; Teive HA; Becker N; Munhoz RP; Werneck LC
    Arq Neuropsiquiatr; 2011 Oct; 69(5):745-50. PubMed ID: 22042174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
    Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
    Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
    Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S;
    J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment.
    Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of botulinum neurotoxin on spatio-temporal gait parameters of patients with chronic stroke: a prospective open-label study.
    Gastaldi L; Lisco G; Pastorelli S; Dimanico U
    Eur J Phys Rehabil Med; 2015 Oct; 51(5):609-18. PubMed ID: 25519765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
    Samotus O; Lee J; Jog M
    J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry.
    Trosch RM; Espay AJ; Truong D; Gil R; Singer C; LeWitt PA; Lew MF; Tagliati M; Adler CH; Chen JJ; Marchese D; Comella CL
    J Neurol Sci; 2017 May; 376():84-90. PubMed ID: 28431634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
    Dressler D; Kupsch A; Seitzinger A; Paus S
    Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait.
    Caty GD; Detrembleur C; Bleyenheuft C; Deltombe T; Lejeune TM
    Stroke; 2008 Oct; 39(10):2803-8. PubMed ID: 18635841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.
    Yi YG; Kim K; Yi Y; Choi YA; Leigh JH; Bang MS
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A.
    Marciniec M; Szczepańska-Szerej A; Papuć E; Rejdak K
    Int J Neurosci; 2022 Oct; 132(10):1026-1030. PubMed ID: 33295845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Botulinum Toxin A Treatment for Pes Varus during Gait.
    Tanikawa H; Kagaya H; Saitoh E; Ozaki K; Hirano S; Itoh N; Yamada J; Kanada Y
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2416-22. PubMed ID: 26232889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatosensory temporal discrimination tested in patients receiving botulinum toxin injection for cervical dystonia.
    Scontrini A; Conte A; Fabbrini G; Colosimo C; Di Stasio F; Ferrazzano G; Berardelli A
    Mov Disord; 2011 Mar; 26(4):742-6. PubMed ID: 21506155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical dystonia: clinical and therapeutic features in 85 patients.
    Camargo CH; Teive HA; Becker N; Baran MH; Scola RH; Werneck LC
    Arq Neuropsiquiatr; 2008 Mar; 66(1):15-21. PubMed ID: 18392407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
    Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
    Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.
    Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia.
    Costanzo M; Belvisi D; Berardelli I; Maraone A; Baione V; Ferrazzano G; Cutrona C; Leodori G; Pasquini M; Conte A; Fabbrini G; Defazio G; Berardelli A
    Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.